Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The government is encouraging enrichment of food items with micronutrients to remove dietary deficiencies among its citizens, Minister of State for Health and Family Welfare Ashwini Kumar Choubey said.

    In order to promote fortification as a means to address micro nutrient deficiencies, the Food Safety and Standards Authority of India (FSSAI) has operationalised the draft Food Safety and Standards (Fortification of Foods) Regulations, 2016 in October 2016, he said in a written reply to the Rajya Sabha.

    Choubey said FSSAI has established Food Fortification Resource Centre in collaboration with Tata Trusts and various international NGOs working in the field of nutrition as a resource centre to promote large-scale fortification of food and to nudge and facilitate food businesses to adopt fortification as a norm.

    At present, all the major oil producers in the country are voluntarily fortifying at least one brand in their product portfolios, he said.

    The regulations include provisions regarding standards for fortification of food articles namely wheat flour, rice, milk, edible oil and salt with vitamins and minerals, said the minister to a query on the laws for food fortification in the country.

    The FSSAI may from time to time mandate fortification of any food article under the regulations on the directions of the Central or the state governments in consultation with stakeholders, he added.


    The Women and Child Development Ministry and the Human Resource Development Ministry have advised the use of double fortified salt with iron and iodine, wheat flour with iron, folic acid and vitamin B-12, and edible oil with vitamin A and D under their Integrated Child Development Scheme and Mid-day Meal Scheme.

    Under Food Safety and Standards (Prohibition and Restriction on Sales) Regulations, 2011, sale of only iodized salt is permitted for direct human consumption.

    Further, Food Safety and Standards (Food Product Standards and Food Additives) Regulations, 2011 provide that vanaspati should contain synthetic Vitamin A.

    << Back to Pharma News

    Subscribe to PharmaTutor News Alerts by Email

  • The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry entitled “E18 Genomic Sampling and Management of Genomic Data.” The guidance was prepared under the auspices of the International Council for Harmonisation (ICH), formerly the International Conference on Harmonisation.

  • The European Medicines Agency (EMA) has started an urgent review of the multiple sclerosis medicine Zinbryta (daclizumab) following 7 cases of serious inflammatory brain disorders in Germany, including encephalitis and meningoencephalitis, and one case in Spain.

  • The National Pharmaceutical Pricing Authority fixes/revises the price of the Scheduled formulation.

    The scheduled formulations are: Atorvastatin + Aspirin Capsule (Atchol-ASP 150), Nifedipine + Lidocaine Cream (LOXHEAL), Pioglitazone + Gliclazide + Metformin Tablet (GLZ Total), Ibuprofen + Paracetamol Tablet (Brufen Plus), Misoprostol Tablet, Glimepiride + Metformin Tablet, Melphalan + Povidone Injection (Melphalan Injection IP 50mg), Trastuzumab Injection, Vitamin D3
    (Cholecalciferol) (DRISE SURE), Furosemide Injection, Snake Venom Antiserum-Soluble/ Liquid Polyvalent Injection, and Phenobarbitone oral liquid.

  • U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud. The FDA is warning consumers to be alert, and try and steer clear of fraudulent flu products, which may be found online or in retail stores. The agency protecting consumers of unapproved products claiming to prevent, treat or cure influenza, or flu.

  • Zosano Pharma Corp a clinical stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to subjects using its proprietary Adhesive Dermally-Applied Microarray (“ADAM™”) technology, today announced that the previously announced Notice of Allowance of our patent application titled “Method of Rapidly Achieving Therapeutic Concentrations of Triptans for Treatment of Migraines” has resulted in the issuance of a U.S. patent 9,918,932.  The inventors were Dr. Mahmoud Ameri, Dr. Don Kellerman, Dr. Yi Ao, and Dr. Peter Dadonna, all of whom are current or former employees of Zosano.

Subscribe to Pharma News